Haemonetics
HAE
#3835
Rank
A$5.12 B
Marketcap
A$112.81
Share price
1.78%
Change (1 day)
-1.46%
Change (1 year)

Operating Margin for Haemonetics (HAE)

Operating Margin as of July 2026 (TTM): 9.59%

According to Haemonetics's latest financial reports and stock price the company's current Operating Margin is 9.59%. At the end of 2026 the company had an Operating Margin of 9.60%.

Operating Margin history for Haemonetics from 2001 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
20269.60%-38.42%
202515.58%34.33%
202411.60%-4.12%
202312.10%88.86%
20226.41%-23.52%
20218.38%-5%
20208.82%15.86%
20197.61%15.36%
20186.60%-312.76%
2017-3.10%-47.24%
2016-5.88%-271.69%
20153.42%-11.74%
20143.88%-30.66%
20135.59%-54.51%
201212.30%-24.41%
201116.27%29.19%
201012.59%-11.43%
200914.22%-5.02%
200814.97%-6.96%
200716.09%-36.82%
200625.46%63.23%
200515.60%24.03%
200412.58%9.78%
200311.46%-4.79%
200212.03%104.1%
20015.90%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58% 260.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
16.87% 75.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
16.42% 71.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-4.48%-146.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
7.69%-19.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
18.20% 89.78%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
14.13% 47.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus Corporation
CERS
-7.41%-177.27%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.